Radaszkiewicz T - Search Results

1

Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis.

Radaszkiewicz T, Dragosics B, Bauer P. Radaszkiewicz T, et al. Gastroenterology. 1992 May;102(5):1628-38. doi: 10.1016/0016-5085(92)91723-h. Gastroenterology. 1992. PMID: 1568573

2

CHOP-firstline treatment in NHL with unfavorable prognosis--evaluation of therapeutic response and factors influencing prognosis.

Heinz R, Neumann E, Aiginger P, Pont J, Schüller J, Walcher G, Hanak H, Radaszkiewicz T, Sinn E, Wirth M, et al. Heinz R, et al. Among authors: radaszkiewicz t. Blut. 1985 May;50(5):267-76. doi: 10.1007/BF00319752. Blut. 1985. PMID: 3888316 Clinical Trial.

3

Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor Therapy.

Fridrik MA, Greil R, Hausmaninger H, Krieger O, Oppitz P, Stöger M, Klocker J, Neubauer M, Helm W, Pont J, Fazeny B, Hudec M, Simonitsch I, Radaszkiewicz T. Fridrik MA, et al. Among authors: radaszkiewicz t. Ann Hematol. 1997 Oct;75(4):135-40. doi: 10.1007/s002770050330. Ann Hematol. 1997. PMID: 9402845 Clinical Trial.

4

Malabsorption associated with a high-grade-malignant non-Hodgkin's lymphoma, alpha-heavy-chain disease and immunoproliferative small intestinal disease.

Hubmann R, Kaiser W, Radaszkiewicz T, Fridrik M, Zazgornik I. Hubmann R, et al. Among authors: radaszkiewicz t. Z Gastroenterol. 1995 Apr;33(4):209-13. Z Gastroenterol. 1995. PMID: 7793120

5

CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.

Fridrik MA, Hausmaninger H, Linkesch W, Stöger M, Sill H, Neubauer M, Seewann HL, Klocker J, Haidinger R, Schiller L, Pont J, Raudaschl G, Falk M, Radaszkiewicz T. Fridrik MA, et al. Among authors: radaszkiewicz t. J Clin Oncol. 1996 Jan;14(1):227-32. doi: 10.1200/JCO.1996.14.1.227. J Clin Oncol. 1996. PMID: 8558202 Clinical Trial.

6

Ewing tumor after treatment of Ki-1+ anaplastic large cell lymphoma. Therapy-associated secondary neoplasm or unrelated coincidence?

Zoubek A, Simonitsch I, Panzer-Grümayer ER, Ghali D, Pfleiderer C, Haas OA, Mann G, Lang S, Radaszkiewicz T, Gadner H, et al. Zoubek A, et al. Among authors: radaszkiewicz t. Cancer Genet Cytogenet. 1995 Aug;83(1):5-11. doi: 10.1016/s0165-4608(95)00014-3. Cancer Genet Cytogenet. 1995. PMID: 7656205

7

Peripheral T cell lymphoma presenting primarily as lethal midline granuloma.

Chott A, Rappersberger K, Schlossarek W, Radaszkiewicz T. Chott A, et al. Among authors: radaszkiewicz t. Hum Pathol. 1988 Sep;19(9):1093-101. doi: 10.1016/s0046-8177(88)80092-3. Hum Pathol. 1988. PMID: 3262084

8

Monoclonality and polyclonality of plasma cells in Castleman's disease of the plasma cell variant.

Radaszkiewicz T, Hansmann ML, Lennert K. Radaszkiewicz T, et al. Histopathology. 1989 Jan;14(1):11-24. doi: 10.1111/j.1365-2559.1989.tb02110.x. Histopathology. 1989. PMID: 2925176

9

Primary peripheral T cell lymphoma in a kidney transplant under immunosuppression with cyclosporine A.

Ulrich W, Chott A, Watschinger B, Reiter C, Kovarik J, Radaszkiewicz T. Ulrich W, et al. Among authors: radaszkiewicz t. Hum Pathol. 1989 Oct;20(10):1027-30. doi: 10.1016/0046-8177(89)90277-3. Hum Pathol. 1989. PMID: 2529203

10

Peripheral T-cell lymphomas: a clinicopathologic study of 75 cases.

Chott A, Augustin I, Wrba F, Hanak H, Ohlinger W, Radaszkiewicz T. Chott A, et al. Among authors: radaszkiewicz t. Hum Pathol. 1990 Nov;21(11):1117-25. doi: 10.1016/0046-8177(90)90148-x. Hum Pathol. 1990. PMID: 2227919

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results